Compared with the blank control group, the gene expression of Smad2 and Smad3 in the TGF-β1 experimental group was increased while Smad7 was decreased, indicating that TGF-β/Smad pathway may be involved in the process of excessive activation of HSC and hepatic fibrosis. The gene discussed is TGFB1; the disease is Hepatic fibrosis.